These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 19889469

  • 1. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.
    Shikata K, Haneda M, Koya D, Suzuki Y, Tomino Y, Yamada K, Maeda S, Kawakami N, Uzu T, Nishimura M, Sato C, Ogawa D, Makino H, DNETT-Japan Study Group.
    Diabetes Res Clin Pract; 2010 Feb; 87(2):228-32. PubMed ID: 19889469
    [Abstract] [Full Text] [Related]

  • 2. [Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study].
    Gaede PH, Jepsen PV, Parving HH, Pedersen OB.
    Ugeskr Laeger; 1999 Jul 26; 161(30):4277-85. PubMed ID: 10439688
    [Abstract] [Full Text] [Related]

  • 3. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM, RENAAL Study Group.
    Arch Intern Med; 2003 Jul 14; 163(13):1555-65. PubMed ID: 12860578
    [Abstract] [Full Text] [Related]

  • 4. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
    Lambers Heerspink HJ, Fowler MJ, Volgi J, Reutens AT, Klein I, Herskovits TA, Packham DK, Fraser IR, Schwartz SL, Abaterusso C, Lewis J, Collaborative Study Group.
    Diabet Med; 2007 Nov 14; 24(11):1290-5. PubMed ID: 17956455
    [Abstract] [Full Text] [Related]

  • 5. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Nov 14; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with progression of diabetic nephropathy in Japanese elderly patients with type 2 diabetes: sub-analysis of the Japanese Elderly Diabetes Intervention Trial.
    Araki S, Nishio Y, Araki A, Umegaki H, Sakurai T, Iimuro S, Ohashi Y, Uzu T, Maegawa H, Kashiwagi A, Ito H, Japanese Elderly Intervention Trial Research Group.
    Geriatr Gerontol Int; 2012 Apr 14; 12 Suppl 1():127-33. PubMed ID: 22435948
    [Abstract] [Full Text] [Related]

  • 7. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO, Jeffers BW, Gifford N, Schrier RW.
    Diabetes Care; 2000 Apr 14; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [Abstract] [Full Text] [Related]

  • 8. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T, Tamura K, Moriya T, Tanaka K, Konno Y, Kondoh S, Toyoda M, Umezono T, Fujikawa T, Ohsawa M, Dejima T, Maeda A, Wakui H, Haku S, Yanagi M, Mitsuhashi H, Ozawa M, Okano Y, Ogawa N, Yamakawa T, Mizushima S, Suzuki D, Umemura S.
    Clin Exp Hypertens; 2011 Apr 14; 33(4):255-63. PubMed ID: 21699452
    [Abstract] [Full Text] [Related]

  • 9. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ.
    Am J Kidney Dis; 2012 Jan 14; 59(1):75-83. PubMed ID: 22051245
    [Abstract] [Full Text] [Related]

  • 10. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS, Al-Suwaida A, Isnani AC, Al-Harbi A, Alam A.
    Saudi J Kidney Dis Transpl; 2009 May 14; 20(3):402-9. PubMed ID: 19414942
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Excess renal insufficiency among type 2 diabetic patients with dip-stick positive proteinuria in a tertiary hospital.
    Balogun WO, Abbiyesuku FM.
    Afr J Med Med Sci; 2011 Dec 14; 40(4):399-403. PubMed ID: 22783692
    [Abstract] [Full Text] [Related]

  • 14. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM.
    Am J Kidney Dis; 2006 Jan 14; 47(1):78-87. PubMed ID: 16377388
    [Abstract] [Full Text] [Related]

  • 15. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
    Lo MK, Lee KF, Chan NN, Leung WY, Ko GT, Chan WB, So WY, Ng MC, Ho CS, Tam JS, Lam CW, Tong PC, Chan JC.
    Diabetes Obes Metab; 2004 May 14; 6(3):223-30. PubMed ID: 15056131
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study.
    Keane WF, Lyle PA, Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan study.
    Am J Kidney Dis; 2003 Mar 14; 41(3 Suppl 1):S22-5. PubMed ID: 12612946
    [Abstract] [Full Text] [Related]

  • 17. Diabetic nephropathy.
    Ritz E.
    Saudi J Kidney Dis Transpl; 2006 Dec 14; 17(4):481-90. PubMed ID: 17186681
    [Abstract] [Full Text] [Related]

  • 18. Are glomerular lesions alternatives to microalbuminuria in predicting later progression of diabetic nephropathy?
    Shoji T, Kanda T, Nakamura H, Hayashi T, Okada N, Nakanishi I, Shimizu Y, Tsubakihara Y.
    Clin Nephrol; 1996 Jun 14; 45(6):367-71. PubMed ID: 8793227
    [Abstract] [Full Text] [Related]

  • 19. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO, Coll JR, Tran ZV, Schrier RW.
    Am J Hypertens; 2006 Dec 14; 19(12):1241-8. PubMed ID: 17161769
    [Abstract] [Full Text] [Related]

  • 20. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M, Kishikawa H, Ohkubo Y, Wake N.
    Diabetes Care; 2000 Apr 14; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.